Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on
October 30, 2012
SEATTLE, Oct. 26, 2012
SEATTLE, Oct. 26, 2012 /PRNewswire/ --On Tuesday, October 30, 2012, at 8:30
a.m. Eastern/1:30 p.m. Central European/5:30 a.m. Pacific, members of Cell
Therapeutics, Inc.'s (CTI) (NASDAQ and MTA: CTIC) management team will host a
conference call to discuss the Company's 2012 third quarter achievements and
Conference Call Numbers
Tuesday, October 30^th
8:30 a.m. Eastern/1:30 p.m. Central European/5:30 a.m. Pacific Time
1-877-941-2333 (US Participants)
Call-back numbers for post-listening available at 11:30 a.m. Eastern:
1- 800-406-7325 (US Participants)
1- 303-590-3030 (International)
Passcode: 4572038 #
Live audio webcast at www.celltherapeutics.com will be archived for post
listening approximately two hours after call ends.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed to
developing an integrated portfolio of oncology products aimed at making cancer
more treatable. For additional information, please visit
Sign up for email alerts and get RSS feeds at our Web site,
Media Contact: Investors Contact:
Dan Eramian Ed Bell
T: 206.272.4343 T: 206.272.4345
C: 206.854.1200 E: firstname.lastname@example.org
F: 206.272.4434 www.celltherapeutics.com/investors
SOURCE Cell Therapeutics, Inc.
Press spacebar to pause and continue. Press esc to stop.